Toxocariasis Treatment & Management
- Author: Sun Huh, MD, PhD; Chief Editor: Mark R Wallace, MD, FACP, FIDSA more...
Chemotherapy is the treatment of choice in most patients with liver, lung, or eye involvement. Occasionally, ocular involvement requires ocular surgery.
Treatment includes mebendazole, thiabendazole, corticosteroids, and specific organ treatment. The prognosis of toxocariasis is generally favorable.
For liver or lung involvement, no surgical care is required.
For ocular involvement with retinal detachment, laser treatment may be considered.
A consultation with an ophthalmologist is indicated in cases of ocular larva migrans.
Consultation with a neurologist is indicated in cases of brain involvement with neurologic symptoms or seizures.
Consultation with an infectious disease specialist may be indicated when questions exist regarding the indications for and selection of treatment for visceral larva migrans.
No diet restrictions are required.
No activity restriction is required.
Moreira GM, Telmo PD, Mendonça M, Moreira AN, McBride AJ, Scaini CJ, et al. Human toxocariasis: current advances in diagnostics, treatment, and interventions. Trends Parasitol. 2014 Sep. 30(9):456-464. [Medline].
Centers for Disease Control and Prevention. Ocular toxocariasis--United States, 2009-2010. MMWR Morb Mortal Wkly Rep. 2011 Jun 10. 60(22):734-6. [Medline].
Nelson S, Greene T, Ernhart CB. Toxocara canis infection in preschool age children: risk factors and the cognitive development of preschool children. Neurotoxicol Teratol. 1996 Mar-Apr. 18(2):167-74. [Medline].
Chomel BB, Kasten R, Adams C, et al. Serosurvey of some major zoonotic infections in children and teenagers in Bali, Indonesia. Southeast Asian J Trop Med Public Health. 1993 Jun. 24(2):321-6. [Medline].
Magnaval JF, Michault A, Calon N, et al. Epidemiology of human toxocariasis in La Réunion. Trans R Soc Trop Med Hyg. 1994 Sep-Oct. 88(5):531-3. [Medline].
CDC. CDC Guidelines for Veterinarians: Prevention of Zoonotic Transmission of Ascarids and Hookworms of Dogs and Cats. Available at http://www.cdc.gov/NCIDOD/DPD/PARASITES/ascaris/prevention.htm.
CDC. Centers for Disease Control and Prevention (CDC). Available at http://www.cdc.gov/NCIDOD/DPD/PARASITES/toxocara/factsht_toxocara.htm.
Choi D, Lim JH, Choi DC, et al. Transmission of Toxocara canis via Ingestion of Raw Cow Liver: A Cross-Sectional Study in Healthy Adults. Korean J Parasitol. 2012 Mar. 50(1):23-7. [Medline]. [Full Text].
Congdon P, Lloyd P. Toxocara infection in the United States: the relevance of poverty, geography and demography as risk factors, and implications for estimating county prevalence. Int J Public Health. 2011 Feb. 56(1):15-24. [Medline].
Iddawela RD, Rajapakse RP, Perera NA, et al. Characterization of a Toxocara canis species-specific excretory-secretory antigen (TcES-57) and development of a double sandwich ELISA for diagnosis of visceral larva migrans. Korean J Parasitol. 2007 Mar. 45(1):19-26. [Medline].
Kwon SI, Lee JP, Park SP, Lee EK, Huh S, Park IW. Ocular toxocariasis in Korea. Jpn J Ophthalmol. 2011 Mar. 55(2):143-7. [Medline].
Magnaval JF. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasitology. 1995 Jun. 110 (Pt 5):529-33. [Medline].
Magnaval JF, Fabre R, Maurieres P, et al. Application of the western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol Res. 1991. 77(8):697-702. [Medline].
Magnaval JF, Fabre R, Maurieres P, et al. Evaluation of an immunoenzymatic assay detecting specific anti-Toxocara immunoglobulin E for diagnosis and posttreatment follow-up of human toxocariasis. J Clin Microbiol. 1992 Sep. 30(9):2269-74. [Medline].
Magnaval JF, Glickman LT, Dorchies P, et al. Highlights of human toxocariasis. Korean J Parasitol. 2001 Mar. 39(1):1-11. [Medline].
Magnaval JF, Malard L, Morassin B, et al. Immunodiagnosis of ocular toxocariasis using Western-blot for the detection of specific anti-Toxocara IgG and CAP for the measurement of specific anti-Toxocara IgE. J Helminthol. 2002 Dec. 76(4):335-9. [Medline].
Moiyadi A, Mahadevan A, Anandh B, et al. Visceral larva migrans presenting as multiple intracranial and intraspinal abscesses. Neuropathology. 2007 Aug. 27(4):371-4. [Medline].
Muñoz-Guzmán MA, del Río-Navarro BE, Valdivia-Anda G, Alba-Hurtado F. The increase in seroprevalence to Toxocara canis in asthmatic children is related to cross-reaction with Ascaris suum antigens. Allergol Immunopathol (Madr). 2010 May-Jun. 38(3):115-21. [Medline].
Park HY, Lee SU, Huh S, et al. A seroepidemiological survey for toxocariasis in apparently healthy residents in Gangwon-do, Korea. Korean J Parasitol. 2002 Sep. 40(3):113-7. [Medline].
Park SP, Huh S, Magnaval JF, et al. A case of presumed ocular toxocariasis in a 28-year old woman. Korean J Ophthalmol. 1999 Dec. 13(2):115-9. [Medline].
Park SP, Park I, Park HY, et al. Five cases of ocular toxocariasis confirmed by serology. Korean J Parasitol. 2000 Dec. 38(4):267-73. [Medline].
Smith HV. Antibody reactivity in human toxocariasis. Lewis JW, Maizels RM, eds. Toxocara and Toxocariasis: Clinical, Epidemiological, and Molecular Perspectives. London: Institute of Biology and the British Society for Parasitology; 1993. 91-109.
Sun T, Bellosa ML, Lucio-Forster A, et al. A comparison of the protein constituents of the major body compartments of the dog roundworm, Toxocara canis. Vet Parasitol. 2007 Nov 30. 150(1-2):111-5. [Medline].
Won K, Kruszon-Moran D, Schantz P, et al. Abstract of the 56th American Society of Tropical Medicine and Hygiene. National seroprevalence and risk factors for zoonotic Toxocara spp. infection. Philadelphia, Pennsylvania; Nov 4-8, 2007.